Ranked #3,912 of 8,699 institutional investors
MIC Capital Management UK LLP
London, X0
$439M
US stock portfolio at live prices · today −$5.7M (−1.28%)
Live prices, last trade 12:09 PM ET
- Value at quarter end (Q3 2026)
- $463M
- Change from Q2 2026
- +$69.0M (+17.51%)
- Positions
- 12 · 4 new, 5 sold out
- Filed
- Nov 13, 2026
Not counted in the ranking: none$10.6M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesOTF 61.3%HAYW 19.7%RXRX 4.77%ETRA 3.86%PRSD 2.25%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| OTF Blue Owl Technology Finance Corp. | 29,787,804 | $269M | 61.3% | New |
| HAYW Hayward Holdings, Inc. | 5,350,873 | $86.6M | 19.7% | Reduced −13% |
| RXRX Recursion Pharmaceuticals, Inc. | 8,255,144 | $21.0M | 4.77% | Reduced −14% |
| ETRA Electra Therapeutics, Inc. | 1,977,170 | $16.9M | 3.86% | New |
| PRSD State Street Short Duration Ig Public & Private Credit ETF | 399,680 | $9.9M | 2.25% | New |
| PRIV State Street IG Public & Private Credit ETF | 401,445 | $9.8M | 2.22% | New |
| COF Capital One Financial Corporation | 48,011 | $8.7M | 1.99% | Unchanged |
| ACHR Archer Aviation Inc. | 700,000 | $2.1M | 0.47% | Unchanged |
| RKLB Rocket Lab Corporation | 35,628 | $1.7M | 0.38% | Unchanged |
| NMRA Neumora Therapeutics, Inc. | 4,460,700 | $1.4M | 0.33% | Unchanged |
| LYEL Lyell Immunopharma, Inc. | 87,028 | $1.2M | 0.27% | Unchanged |
| BLLN BillionToOne, Inc. | 4,892 | $439K | <0.1% | Unchanged |